1
/
of
0
FDA Drug Approval, N020186, ZIAC
FDA Drug Approval, N020186, ZIAC
Regular price
$149.00 USD
Regular price
Sale price
$149.00 USD
Unit price
/
per
NDA: 020186
Company: TEVA BRANDED PHARM
Drug Name: ZIAC
Active Ingredients: BISOPROLOL FUMARATE; HYDROCHLOROTHIAZIDE
Strength: 2.5MG;6.25MG
Dosage Form/Route: TABLET;ORAL
Action Date: 03/26/1993
Marketing Status: Prescription
Submission Classification: Type 4 - New Combination
Company: TEVA BRANDED PHARM
Drug Name: ZIAC
Active Ingredients: BISOPROLOL FUMARATE; HYDROCHLOROTHIAZIDE
Strength: 2.5MG;6.25MG
Dosage Form/Route: TABLET;ORAL
Action Date: 03/26/1993
Marketing Status: Prescription
Submission Classification: Type 4 - New Combination
Couldn't load pickup availability
- Status: Pending Fast-Track Request
- Delivery: Approximately 1 to 2 weeks
NOTE: This document is not currently in our library. Upon purchase, we will request the document from the FDA FOIA office. Learn more about Fast-Track Requests here.
View full details